logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Neratinib gets nod for metastatic HER2-positive breast cancer

Neratinib, with capecitabine, is approved for recipients of 2 or more prior therapies.